Gerry DiFiore, partnered with the global law firm of Reed Smith is specialized in securities law on emerging growth companies. He recently co-authored a paper on the Jobs Act.
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedPlace kicked off OneMedForum NY 2012 with an exclusive investor networking reception to raise awareness about the upcoming 3rd annual finance conference.
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face […]
The company’s lead product, SwiftPayMD is a recently launched mobile app for iPad and iPhone that helps doctors work more efficiently when seeing patients at the hospital.
OneMedResearch recently initiated coverage on Opexa Therapeutics, a biotechnology company developing patient-specific cellular therapies for the treatment of autoimmune diseases.
Valued at almost $6bn in the seven major markets in 2011 (US, Japan, France, Germany, Italy, Spain, and the UK), the Alzheimer’s disease drug market is forecast to experience double-digit growth to 2020.
Below Christian Haller and Marcus Hadley of MPR Associates discuss successful product development processes. They note three main characteristics: 1) clear direction and leadership from […]
The final interview in our MPR series is with Leon Marucchi, Director of Industrial Design and Katie McHugh, a design engineer at the international consulting firm.
Copyright © 2025 | WordPress Theme by MH Themes